U.S. High Court Asked To Clarify ‘Clear Evidence’ Of FDA Labeling Decisions
WASHINGTON, D.C. — Johnson & Johnson and McNeil-PPC Inc. on Oct. 8 asked the U.S. Supreme Court to decide if a Food and Drug Administration response to a citizen petition regarding...To view the full article, register now.
Already a subscriber? Click here to view full article